United Therapeutics Stock
Price
Target price
€251.90
€251.90
-0.120%
-0.3
-0.120%
€288.66
16:33 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
United Therapeutics shows a slight decrease today, losing -€0.300 (-0.120%) compared to yesterday.
United Therapeutics is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 288 € shows a slightly positive potential of 14.33% compared to the current price of 251.9 € for United Therapeutics.
Pros and Cons of United Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | -0.120% | 2.771% | 12.892% | 24.114% | 27.213% | 61.667% | 211.281% |
| Ironwood Pharmaceuticals | -2.520% | -7.200% | -21.088% | -39.896% | -43.137% | -41.117% | - |
| Novocure Ltd | 11.220% | 32.158% | 78.326% | -72.485% | 41.786% | -86.061% | - |
| Iovance Biotherapeutics Inc. | 1.380% | -7.525% | -11.439% | 38.319% | 20.569% | -29.851% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for UTHR provided by MarketBeat
